Form D · Other Health Care
Hansen Pharmaceutical, LLC
South Miami, FL · CIK 0001628069
Offering snapshot reported Dec 16, 2014 · SEC filing
- Reported sold
- $200K Offering amount: $200K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Nov 19, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 16, 2014 | Initial | $200,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-230192
Source: Form D, filed Dec 16, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jason R. Hanft | Director, Executive |
| Jeffrey L. Jensen | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
7000 Sw 62 Nd Avenue, Suite 310
South Miami, FL, 33413
South Miami, FL, 33413